# Lexeo Therapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2025

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 10-Q/A
- Filed: 2025-05-15
- Accepted by EDGAR: May 14, 2025, 18:22 ET
- Period: 2025-03-31
- Accession: 0000950170-25-071709
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017025071709/lxeo-20250331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017025071709/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017025071709/lxeo-20250331.htm

Filed May 15, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-071709. Last ingested by Listed: Oct 29, 2026, 07:31 ET. No prices; not investment advice.